Kyocera’s Aquala artificial hip joint technology recognized by Japan Institute of Invention and Innovation — 3 insights

The Japan Institute of Invention and Innovation awarded Kyocera’s Aquala artificial hip joint technology its Prize of the Minister of Economy, Trade and Industry.

Advertisement

Here’s what you should know:

1. Kyocera received the honor for its surface-processing technology, which was developed in collaboration with the University of Tokyo.

2. The technology extends the life expectancy of artificial hip joints by reducing the incidence of wear particles at the joint’s bearing surface.

3. Since its 2011 approval, around 45,000 procedures have been completed with the technology.

More articles on orthopedics:
TVA Medical to introduce FDA-approved endovascular fistula creation method at surgery centers — 5 insights
Implementing a total joint replacement program in your ASC: 4 lessons from OrthoIllinois Surgery Center
30k joint replacements for SurgCenter Development & more — 8 ASC company key notes

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in Orthopedics / TJR

Advertisement

Comments are closed.